BICO Group
40,57 SEK -5,19 %1 investor følger denne virksomhed
BICO Group is active in medical technology. The company specializes in bio convergence and provides technology, products, and services for biology. With a focus on the application areas bioprinting, multi-omics, cell line development, and diagnostics, the company develops and markets technology that enables researchers to grow cells in 3D environments, conduct drug screening, and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries.
Omsætning
2,24 mia.
EBIT %
-44,51 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
BICO
Daglig lav / høj pris
40,1 / 42,59
SEK
Markedsværdi
2,8 mia. SEK
Aktieomsætning
13,47 mio. SEK
Volumen
329 t
Seneste videoer
Finanskalender
Delårsrapport
22.08.2023
Delårsrapport
14.11.2023
Årsrapport
20.02.2024
Viser Alle indholdstyper
